Ambrx Biopharma Inc. EBITDA Margin 2023-2023 | AMAM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ambrx Biopharma Inc. (AMAM) over the last 10 years. The current EBITDA margin for Ambrx Biopharma Inc. as of June 30, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-06-30 | $0.00B | $-0.05B | -1733.33% |
